Open-label, randomized parallel group trial on the efficacy and safety of intra-articular administration of bevacizumab for knee osteoarthritis.
Not Applicable
Recruiting
- Conditions
- Osteoarthritis of knee joints
- Registration Number
- JPRN-UMIN000008260
- Lead Sponsor
- ational Hospital Organization Sagamihara Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who do not have any significant physical, neurological, or mental problems. 2. Patients who do not have any significant disorders in motor systems. 3. Patients who are inadequate to enter the trial by physicians' judgments
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the symptoms before and after the administration of bevacizumab.
- Secondary Outcome Measures
Name Time Method